ORIGINAL RESEARCH

RNA interference targeting interstitial collagenase is a potential therapeutic tool to treat psoriasis

Mogulevtseva YuA1, Mezentsev AV2, Bruskin SA2
About authors

1 Russian State Agrarian University – Timiryazev Moscow Agricultural Academy, Moscow, Russia

2 Laboratory of Functional Genomics, Department of Genetics and Biotechnology,
Vavilov Institute of General Genetics of the Russian Academy of Sciences, Moscow, Russia

Correspondence should be addressed: Aleksandr Mezentsev
ul. Gubkina, d. 3, Moscow, Russia, 119333; ur.ggiv@vestnesem

About paper

Acknowledgements: the authors thank Prof. Eleonora Piruzian of Vavilov Institute of General Genetics for a critical analysis of the manuscript and Prof. Maria Lagarkova of Vavilov Institute of General Genetics for the plasmids used in this study.

Contribution of all authors in data collection, analysis and interpretation was equal. Mogulevtseva AYu prepared all illustartions and Mezentsev AV drafted a manuscript. All authors participated in editing of the manuscript.

Received: 2017-02-17 Accepted: 2017-03-25 Published online: 2017-07-19
|
  1. Sabat R, Philipp S, Höflich C, Kreutzer S, Wallace E, Asadullah K et al. Immunopathogenesis of psoriasis. Exp Dermatol. 2007; 16 (10): 779–98. PubMed PMID: 17845210.
  2. Mezentsev A, Nikolaev A, Bruskin S. Matrix metalloproteinases and their role in psoriasis. Gene. 2014; 540 (1): 1–10. PubMed PMID: 24518811.
  3. Corbitt CA, Lin J, Lindsey ML. Mechanisms to inhibit matrix metalloproteinase activity: where are we in the development of clinically relevant inhibitors? Recent Pat Anticancer Drug Discov. 2007; 2 (2): 135–42. PubMed PMID: 18221058.
  4. Peterson JT. The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors. Cardiovasc Res. 2006; 69 (3): 677–87. PubMed PMID: 16413004.
  5. Shi Q, Zhang XL, Dai KR, Benderdour M, Fernandes JC. siRNA therapy for cancer and non-lethal diseases such as arthritis and osteoporosis. Expert Opin Biol Ther. 2011; 11 (1): 5–16. PubMed PMID: 21058934.
  6. Schambach A, Baum C. Clinical application of lentiviral vectors - concepts and practice. Curr Gene Ther. 2008; 8 (6): 474–82. PubMed PMID: 19075630.
  7. Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996; 272 (5259): 263–7. PubMed PMID: 8602510.
  8. Köllisch G. Kalali BN, Voelcker V, Wallich R, Behrendt H, Ring J et al. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology. 2005; 114 (4): 531–41. PubMed PMID: 15804290.
  9. Olaru F, Jensen LE. Chemokine expression by human keratinocyte cell lines after activation of Toll-like receptors. Exp Dermatol. 2010; 19 (8): e314–6. PubMed PMID: 20100199.
  10. Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008; 17 (12): 1063–72. PubMed PMID: 19043850.
  11. Mogulevtseva Yu, Mezentsev AV. Klonirovanie posledovatel'nosti maloy ingibiruyushchey RNK, spetsifichnoy k metalloproteinaze 1 cheloveka, v ekspressionnyy vektor pGPV-17019250. Wschodnioeuropejskie Czasopismo Naukowe. 2016; (9): 85–92. Russian.
  12. Mogulevtseva Yu, Mezentsev AV. Molekulyarnyy dizayn i klonirovanie kontrol'noy RNK dlya provedeniya eksperimentov po RNK-interferentsii interstitsial'noy kollagenazy cheloveka. In: Sbornik statey studentov, magistrantov, aspirantov, molodykh uchenykh i prepodavateley «Razvitie sovremennoy nauki: teoreticheskie i prikladnye aspekty»; 2016 Aug 4; Perm, 2016; (6): 70–7. Russian.
  13. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227 (5259): 680–5. PubMed PMID: 5432063.
  14. Meyer TS, Lamberts BL. Use of coomassie brilliant blue R250 for the electrophoresis of microgram quantities of parotid saliva proteins on acrylamide-gel strips. Biochim Biophys Acta. 1965; 107 (1): 144–5. PubMed PMID: 4159310.
  15. Gogly B, Groult N, Hornebeck W, Godeau G, Pellat B. Collagen zymography as a sensitive and specific technique for the determination of subpicogram levels of interstitial collagenase. Anal Biochem. 1998; 255 (2): 211–6. PubMed PMID: 9451506.
  16. Chomczynski P, Mackey K. Short technical reports. Modification of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources. Biotechniques. 1995; 19 (6): 942–5. PubMed PMID: 8747660.
  17. Probes [Internet]. Bethesda (MD): National Library of Medicine (US); [cited 2017 Feb 10] Available from: https://www.ncbi.nlm.nih.gov/probe/
  18. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010; 141 (1): 52–67. PubMed PMID: 20371345.
  19. Momota Y, Suzuki N, Kasuya Y, Kobayashi T, Mizoguchi M, Yokoyama F et al. Laminin α3 LG4 module induces keratinocyte migration: involvement of matrix metalloproteinase-9. J Recept Signal Transduct Res. 2005; 25 (1): 1–17. PubMed PMID: 15960391.
  20. Swindell WR, Johnston A, Carbajal S, Han G, Wohn C, Lu J et al. Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PLoS One. 2011; 6 (4): e18266. PubMed PMID: 21483750.
  21. Zhang X, Jin JY, Wu J, Qin X, Streilein R, Hall RP et al. RNA- Seq and ChIP-Seq reveal SQSTM1/p62 as a key mediator of JunB suppression of NF-κB-dependent inflammation. J Invest Dermatol. 2015; 135 (4): 1016–24. PubMed PMID: 25501661.
  22. Matsui T, Amagai M. Dissecting the formation, structure and barrier function of the stratum corneum. Int Immunol. 2015; 27 (6): 269–80. PubMed PMID: 25813515.
  23. Rao KS, Babu KK, Gupta PD. Keratins and skin disorders. Cell Biol Int. 1996; 20 (4): 261–74. PubMed PMID: 8664850.
  24. Al Robaee AA. Molecular genetics of Psoriasis (Principles, technology, gene location, genetic polymorphism and gene expression). Int J Health Sci (Qassim). 2010; 4 (2): 103–27.
  25. Iizuka H, Takahashi H, Honma M, Ishida-Yamamoto A. Unique keratinization process in psoriasis: late differentiation markers are abolished because of the premature cell death. J Dermatol. 2004; 31 (4) 271–6.